Home > Healthcare > Medical Devices > Therapeutic Devices > Carboxy Therapy Market

Carboxy Therapy Market Size

  • Report ID: GMI6463
  • Published Date: Aug 2023
  • Report Format: PDF

Carboxy Therapy Market Size

Carboxy Therapy Market size was valued at USD 98.4 million in 2022 and is estimated to account for USD 310.5 million by 2032. Carboxy therapy is a non-surgical cosmetic and medical treatment wherein medical-grade carbon dioxide gas is injected into the skin surface.

 

The injected carbon dioxide gas promotes increased blood circulation, collagen production, and tissue oxygenation in the treated area. It is used for cosmetic purposes, such as reducing cellulite, stretch marks, and dark circles, while also showing potential medical applications for conditions such as peripheral vascular diseases and diabetic foot ulcers. Carboxy therapy has been experiencing steady growth over the past few years due to its non-invasive nature and a wide range of applications. The rising demand for non-surgical cosmetic procedures, coupled with increasing awareness about the benefits of carboxy therapy is anticipated to augment market expansion.

 

The increasing awareness about benefits of carboxy therapy and the availability of portable devices have made the procedure more accessible to both practitioners and patients. For instance, DTA Medical has introduced the Carbo2 HP, an innovative trolley-mounted carboxytherapy unit that offers easy-tech instruments for precise micro-injection of medicinal carbon dioxide (CO2) under the skin (subcutaneously) or within the dermis (intra-dermally). Furthermore, the unit features specialized software capable of handling standard and personalized treatment programs. This technology ensures optimal safety and effectiveness during carboxytherapy procedures. Thus, portable devices allow for more flexibility in treatment settings, making carboxy therapy feasible in various clinical and non-clinical settings.

 

As the global population ages, the demand for anti-aging treatments has surged. Carboxy therapy, with its ability to stimulate collagen production and improve skin texture, has become a popular choice for individuals seeking to reduce the signs of aging, such as wrinkles, fine lines, and sagging skin. Thus, as the industry continues to evolve, further advancements and innovations are likely to enhance the efficacy and popularity of carboxy therapy as a sought-after cosmetic and medical treatment option, thereby estimated to accelerate market progress.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

The global market for carboxy therapy was valued at USD 98.4 million in 2022 and is estimated to account for USD 310.5 million by 2032, owing to the rising demand for non-surgical cosmetic procedures.

The aesthetic medicine segment garnered USD 28.9 million revenue size in the year 2022, backed by the carboxy therapy's versatile cosmetic applications, addressing concerns such as cellulite, stretch marks, and dark circles that attracts a large number of patients seeking non-surgical alternatives.

U.S. carboxy therapy market accounted for USD 36.4 million in 2022 and is predicted to witness substantial growth through 2032. Advanced healthcare infrastructure ensuring widespread accessibility to safe & effective carboxy therapy services for aesthetic treatments will accelerate market growth.

DTA Medical, Cosmopro, Carbossiterapia Italiana, Mezopharma, MBE Medical Divisions, Beijing Jontelaser Technologies Co., Ltd., Alvi Prague, Kastner-Praxisbedarf, MEDAiON Plasma, Easymedical Group, and Innoaesthetics.

Carboxy Therapy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 345
  • Countries covered: 21
  • Pages: 227
 Download Free Sample